OR WAIT null SECS
The HCPLive acne page is a resource for medical news and expert insights on dermatological disease. This page features expert-led coverage, articles, videos, and research on the therapies and development of treatments for chronic acne, and more.
January 08, 2024
Article
These findings highlight the real access barriers faced by TGD individuals as well as the necessity of additional research to promote evidence-based hormonal acne treatments.
December 11, 2023
Given the lack of widespread awareness of the magnitude and prevalence of the public’s stigma toward people with acne, this research sought to expand upon this body of research.
October 30, 2023
This new data highlights the value of proper counseling regarding possible adverse effects prior to initiation of treatment initiation with JAK inhibitors.
October 22, 2023
Video
In this interview, Dr. Eichenfield shared his views on this week’s approval by the FDA of IDP-126 for patients 12 and older with acne.
October 21, 2023
Designed to treat the acne's inflammation, bacteria and follicular hyperkeratinization, IDP-126 has shown significant efficacy compared to standard-care options already on the market.
In this interview segment, Dr. Nestor speaks on some of his biggest takeaways from his talk ‘What’s Coming Up Next?’ given at the Fall Clinical Dermatology conference.
September 05, 2023
Given that this new research was an exploratory study with a smaller sample size, the study’s results may not be generalized and future studies should use more patients and institutions.
August 19, 2023
This new research letter highlights several trends in prescribing by both dermatologists and non-dermatologists from 2017 to 2020.
August 16, 2023
This new data from China showed that both the duration of mask-wearing and greater use of facial cleansing may result in skin deterioration, though moisturizing products were found to have more positive effects.
July 05, 2023
From a novel acne cream to a breakthrough depression drug, a half-dozen agent decisions are coming through in the coming 6 months.